Conba Group’s subsidiary Zhejiang Conba Pharmaceutical has completed the sale of 57.3% stake in a pharmaceutical company.

"Zhejiang Conba has received a consideration of ¥345.1m ($50.27m) from the stake sale."

Zhejiang Conba has received a consideration of ¥345.1m ($50.27m) from the stake sale.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Based in China, Zhejiang Conba Pharmaceutical sells medicines and chemical products.

Chabiotech subsidiary CHA Healthcare has reached an agreement to acquire 8.8% stake in Singapore Medical Group.

The stake represents 30 million shares of the target company and costs KRW12.07bn ($10.23m) for the acquirer company.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Recognised with 2025 Excellence Awards for Research and Development and Marketing , Novotech converted FDA/EMA fast track designations into faster HDV trial timelines while translating complex HBV science into sponsor ready insights. Discover how this dual strength in execution and communication is reshaping liver disease clinical development.

Discover the Impact